Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypersensitivity to VM-26].

B Köster, J Ritter, U Bode

    Klinische Padiatrie
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Anaphylactic reactions to VM-26 (teniposide) are rare but serious. Pre-treatment with dexamethasone prevented recurrence in two neuroblastoma patients experiencing these severe allergic events.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Monitoring of shallow groundwater in Lower Saxony, Germany-spatial variability of redox conditions and benefit of the redox proxy ∆<sub>Mn-Fe</sub>.

    Environmental monitoring and assessment·2025
    Same author

    Design of target irradiation and diagnostic chamber to study ps-laser generated plasma as a source of singly charged ions for external injection into an electron beam ion source.

    The Review of scientific instruments·2020
    Same author

    Risk detection in patients with obstructive sleep apnea syndrome based on cardiovascular time series analysis<sup>.</sup>

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020
    Same author

    Development of highly efficient NEG pumping system for EBIS.

    The Review of scientific instruments·2019
    Same author

    Fate of Selected Pathogens Inoculated into Foods Prepared in Slow Cookers <sup>1,</sup> <sup>2</sup>.

    Journal of food protection·2019
    Same author

    Reliability and consistency of a validated sun exposure questionnaire in a population-based Danish sample.

    Preventive medicine reports·2018
    Same journal

    Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study Group.

    Klinische Padiatrie·2026
    Same journal

    Klinische Padiatrie·2026
    Same journal

    Association of Fat-free Mass Index and Body Mass Index on Pulmonary Function Tests in Children with Rheumatological Disease-associated Interstitial Lung Disease.

    Klinische Padiatrie·2026
    Same journal

    Synchronous Differentiated Thyroid Carcinoma and Nonthyroid Malignancies in Pediatric Patients: A Registry-based Case Series.

    Klinische Padiatrie·2026
    Same journal

    Intrauterine Ulceration of the Lower Limbs: A Not-so-rare Complication Following Vesicoamniotic Shunting with Somatex.

    Klinische Padiatrie·2026
    Same journal

    Letter to the Editor Regarding the Article "Near-Fatal Asthma Due to Severe Airway Mucus Plugging in a 12-Year-Old Boy".

    Klinische Padiatrie·2026
    See all related articles

    Area of Science:

    • Oncology
    • Pharmacology
    • Immunology

    Background:

    • VM-26 (teniposide) is a chemotherapeutic agent used in pediatric neuroblastoma treatment.
    • The German neuroblastoma therapy protocol GPO-NB-82 utilizes VM-26 in combination regimens.
    • Anaphylaxis is a rare but potentially life-threatening allergic reaction.

    Observation:

    • Two pediatric patients in the GPO-NB-82 protocol experienced anaphylactic reactions following their initial VM-26 administration.
    • These reactions occurred during the first application of VM-26 in the treatment protocol.
    • The severity of the reactions necessitated immediate medical attention.

    Findings:

    • Subsequent administrations of VM-26, when combined with dexamethasone, did not result in recurrent anaphylactic reactions in these patients.

    Related Experiment Videos

  • Dexamethasone appears to mitigate or prevent the hypersensitivity response to VM-26.
  • This suggests a potential prophylactic strategy for managing VM-26-induced anaphylaxis.

    • Implications:

    • The findings suggest that dexamethasone pre-treatment could be a valuable strategy to prevent anaphylaxis in patients receiving VM-26.
    • This approach may allow for the continued use of VM-26 in neuroblastoma treatment for patients at risk of allergic reactions.
    • Further research is warranted to confirm the efficacy and optimal dosing of dexamethasone for preventing VM-26-associated anaphylaxis in broader patient populations.